SEATTLE: NanoString Technologies Inc, a leading provider of life science tools for discovery and translational research, announced the availability of new solutions to study the immune response in COVID-19 disease research. As part of an expanding portfolio of infectious disease research solutions, the nCounter Host Response Gene Expression Panel and COVID -19 Panel Plus spike-in…